The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

Share Price Information for De La Rue (DLAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.20 (4.656%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 94.00
DLAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Meeting

2 Dec 2022 16:42

RNS Number : 4999I
De La Rue PLC
02 December 2022
 

 

 

 

DE LA RUE PLC

 

2 December 2022

 

RESULT OF GENERAL MEETING

 

 

A General Meeting of De La Rue plc ("De La Rue" or the "Company") was held at 2:00pm today, 2 December 2022, at De La Rue House, Jays Close, Viables, Basingstoke, Hampshire (the "General Meeting").

The Company is pleased to announce that the only resolution put to the General Meeting, which was to approve Kevin Loosemore continuing as a Director of the Company and as Chairman of the Board, was duly passed by the Company's shareholders on a poll vote. The full text of the resolution is contained in the Notice of General Meeting published on 3 November 2022, which is available on the Company's website at www.delarue.com.

The General Meeting was called in response to a request in October 2022 from an investor in the Company, Crystal Amber Fund Limited ("Crystal Amber"), for the Chairman of the Board, Kevin Loosemore, to resign. Excluding the votes cast by Crystal Amber, 94.9% of the votes cast were in favour of Mr Loosemore continuing to serve as a Director of the Company and as Chairman of the Board.

The Board is pleased that the resolution was passed at today's General Meeting and welcomes the overwhelming support of the Company's shareholders for the resolution proposed. The full results of the poll vote on the resolution, on which Computershare (the Company's registrar) acted as scrutineer, are as follows:

 

RESOLUTION

FOR

AGAINST

TOTAL

WITHHELD

Number of votes

% of votes cast

Number of votes

% of votes cast

Votes cast (excluding withheld)

% of issued share capital

Number of votes

Ordinary Resolution

1.

Approve Kevin Loosemore's continuation as Director and Chairman of De La Rue

125,880,167

 

82.9%

 

26,012,867

 

17.1%

 

151,893,034

 

77.7%

 

165,804

 

 

Notes:

1. The percentages voted 'For' and 'Against' are expressed as a proportion of the total votes cast. Votes 'withheld' are not votes under English law and so have not been included in the calculation of whether the resolution was carried. Percentages have been rounded to one decimal place.

2. Any proxy appointments which gave discretion to the Chairman of the meeting were voted in favour of the resolution and have been included in the 'For' totals.

3. As at 6:00 p.m. on 30 November 2022 (being the record time for the General Meeting), the issued share capital of the Company consisted of 195,435,840 ordinary shares of 44152/175 pence each, carrying one vote each and 111,673,300 deferred shares with a nominal value of 1 penny which do not carry any voting rights. The total number of shares over which voting rights in the Company are held is therefore 195,435,840.

The results of the General Meeting held on 2 December 2022 will shortly be available to view on the Company's website at www.delarue.com. In accordance with Listing Rule 9.6.2R, a copy of the wording of the resolution will be submitted to the National Storage Mechanism, where it will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

Enquiries:

 

De La Rue plc

+44 (0) 7990 337707

Clive Vacher

Chief Executive Officer

Rob Harding

Chief Financial Officer

Louise Rich

Head of Investor Relations

 

 

 

 

 

 

Brunswick

+44 (0)207 404 5959

Stuart Donnelly

 

Ed Brown

 

 

About De La Rue

De La Rue plc's purpose is to secure trust between people, businesses and governments. As a trusted partner of governments, central banks and commercial organisations seeking to secure their global supply chains and cash cycles, De La Rue provides highly secure physical and digital solutions that underpin the integrity of economies and trade.

De La Rue's Currency division provides market-leading end-to-end currency solutions, from finished banknotes to secure polymer substrate and banknote security features to over half the central banks and issuing authorities around the world.

Our Authentication division protects revenues and reputations through the provision of physical and digital solutions to governments and commercial organisations. We also manufacture financial documents and ID security components.

At the end of September 2022, De La Rue had 2,190 employees who work with organisations in more than 140 countries, leveraging the group's manufacturing facilities in the UK, US, Malta, Sri Lanka and Kenya.

De La Rue's shares are traded on the London Stock Exchange (LSE:DLAR). For further information please visit www.delarue.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMTTBFTMTIMBBT
Date   Source Headline
17th Apr 20247:00 amRNSPre-Close Trading Statement
16th Apr 202411:52 amRNSHolding(s) in Company
16th Apr 202410:59 amRNSHolding(s) in Company
3rd Apr 20247:00 amRNSExtension of contract with Microsoft
2nd Apr 202411:25 amRNSTotal Voting Rights
7th Mar 20241:04 pmRNS2023 AGM Voting Update
23rd Feb 20242:06 pmRNSAdditional Listing
29th Jan 20244:14 pmRNSHolding(s) in Company
26th Jan 20244:38 pmRNSDirector/PDMR Shareholding
18th Jan 20243:19 pmRNSHolding(s) in Company
18th Jan 202412:13 pmRNSHolding(s) in Company
2nd Jan 202411:33 amRNSBlock listing Interim Review
21st Dec 20233:51 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNS2023/24 half year results
27th Nov 20232:53 pmRNSHolding(s) in Company
1st Nov 20231:51 pmRNSTotal Voting Rights
30th Oct 202311:05 amRNSHolding(s) in Company
13th Oct 202310:27 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSPre-close Trading Statement
2nd Oct 202311:47 amRNSTotal Voting Rights
20th Sep 202312:59 pmRNSDirector/PDMR Shareholding
13th Sep 20231:09 pmRNSHolding(s) in Company
7th Sep 20231:59 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM statement and trading update
4th Sep 202312:36 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
14th Aug 20233:30 pmRNSHolding(s) in Company
11th Aug 20232:58 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSDirectorate Change
4th Aug 20237:00 amRNSDirectorate Change
3rd Aug 20239:21 amRNSAppointment of Joint Broker
2nd Aug 20233:26 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 20231:44 pmRNSDirector/PDMR Shareholding
24th Jul 20233:04 pmRNSHolding(s) in Company
20th Jul 20234:03 pmRNSHolding(s) in Company
20th Jul 202312:17 pmRNSAnnual Financial Report
19th Jul 20231:01 pmRNSHolding(s) in Company
11th Jul 202310:28 amRNSDirector/PDMR Shareholding
4th Jul 202312:59 pmRNSHolding(s) in Company
3rd Jul 20235:44 pmRNSHolding(s) in Company
3rd Jul 202312:12 pmRNSBlock listing Interim Review
3rd Jul 202312:09 pmRNSTotal Voting Rights
30th Jun 20231:40 pmRNSHolding(s) in Company
30th Jun 20231:35 pmRNSHolding(s) in Company
30th Jun 202310:11 amRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFY23 full year results
28th Jun 20235:25 pmRNSHolding(s) in Company
28th Jun 20231:50 pmRNSHolding(s) in Company
27th Jun 20231:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.